Spouting Rock Asset Management, LLC Aspira Women'S Health Inc. Transaction History

Spouting Rock Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$0.32 - $0.58 $34,730 - $62,949	108,534 Added 268.75%	148,918 $55,000
Q2 2022 Aug 10, 2022	BUY	$0.4 - $1.09 $16,153 - $44,018	40,384 New	40,384 $24,000
Q3 2021 Nov 15, 2021	SELL	$3.19 - $5.48 $146,995 - $252,518	-46,080 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.78 - $6.84 $21,189 - $30,321	4,433 Added 10.64%	46,080 $259,000
Q1 2021 May 17, 2021	SELL	$5.9 - $9.13 $29,623 - $45,841	-5,021 Reduced 10.76%	41,647 $281,000

Q4 2020 Feb 11, 2021	SELL	$3.0 - $6.71 $145,623 - $325,710	-48,541 Reduced 50.98%	46,668 $313,000
Q3 2020 Nov 16, 2020	BUY	$2.54 - $4.56 $18,227 - $32,722	7,176 Added 8.15%	95,209 $294,000
Q2 2020 Aug 03, 2020	BUY	$0.78 - $5.25 $68,665 - $462,173	88,033 New	88,033 $338,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.